380 related articles for article (PubMed ID: 19166180)
1. Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth.
Kazemi A; Koosha A; Rafizadeh B; Mousavinasab N; Mahram M
East Mediterr Health J; 2008; 14(4):960-5. PubMed ID: 19166180
[TBL] [Abstract][Full Text] [Related]
2. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
3. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
4. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran.
Alizadeh AH; Ranjbar M; Ansari S; MirArab A; Alavian SM; Mohammad K; Adibi P; Sadri GH; Keramat F; Ardalan A; Arabi M; Gharekhani S; Ataei A; Amraei GR; Hosseinzadeh M; Hatami S; Zali M
East Mediterr Health J; 2006 Sep; 12(5):528-37. PubMed ID: 17333790
[TBL] [Abstract][Full Text] [Related]
7. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
8. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B revaccination not indicated, even for those at increased risk].
Isken LD; Zaaijer HL; van Steenbergen JE
Ned Tijdschr Geneeskd; 2009; 153():A415. PubMed ID: 19900310
[TBL] [Abstract][Full Text] [Related]
11. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
12. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B infection among Iraqi children: the impact of sanctions.
Ali HY
East Mediterr Health J; 2004; 10(1-2):6-11. PubMed ID: 16201703
[TBL] [Abstract][Full Text] [Related]
14. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran.
Zali MR; Mohammad K; Noorbala AA; Noorimayer B; Shahraz S
East Mediterr Health J; 2005; 11(1-2):62-7. PubMed ID: 16532672
[TBL] [Abstract][Full Text] [Related]
15. [Seroepidemiological analysis of characteristic of hepatitis B virus in children after vaccination in Ningbo].
Chen H; Zhou A; Wang R
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):184-7. PubMed ID: 11860873
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization.
Chongsrisawat V; Yoocharoen P; Theamboonlers A; Tharmaphornpilas P; Warinsathien P; Sinlaparatsamee S; Paupunwatana S; Chaiear K; Khwanjaipanich S; Poovorawan Y
Trop Med Int Health; 2006 Oct; 11(10):1496-502. PubMed ID: 17002723
[TBL] [Abstract][Full Text] [Related]
17. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
[TBL] [Abstract][Full Text] [Related]
18. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
Danielsson N; Fakakovikaetau T; Szegedi E
Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
[TBL] [Abstract][Full Text] [Related]
19. Assessment of anti-HBs antigen in 6- to 9-year-old children routinely vaccinated via vaccination program in Iran.
Hadi N; Hadi N
Med Princ Pract; 2007; 16(4):306-9. PubMed ID: 17541297
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
